Search

everythinglearnresearchcommunity

for

Search:↓

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Ionizing radiation damages human hair follicles by stopping cell growth, causing cell death, disrupting color, and increasing stress and damage markers.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Fat injections in the face can cause hair loss.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.